Results 291 to 300 of about 6,673,815 (394)

Beyond a Single Marker: An Update on the Comprehensive Evaluation of Right Ventricular Dysfunction in Pulmonary Thromboembolism. [PDF]

open access: yesLife (Basel)
Cucută S   +8 more
europepmc   +1 more source

Transcoronary study of biomarkers in patients with heart failure: Insights into intracardiac production

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 1640-1651, June 2025.
Abstract Aims Biomarkers are pivotal in the management of heart failure (HF); however, their lack of cardiac specificity could limit clinical utility. This study aimed to investigate the transcoronary changes and intracardiac production of these biomarkers.
Jie Ren   +10 more
wiley   +1 more source

A holistic approach to managing cardio-kidney metabolic syndrome: insights and recommendations from the Italian perspective. [PDF]

open access: yesFront Cardiovasc Med
Iacoviello M   +5 more
europepmc   +1 more source

The effect of trimetazidine on cardiac haemodynamics and mitochondrial function in wild‐type transthyretin amyloidosis

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 1796-1806, June 2025.
Abstract Aims Wild‐type transthyretin cardiac amyloidosis (ATTRwt) is a cardiomyopathy causing myocardial hypoperfusion and impaired cardiac mitochondrial function. Trimetazidine is an antianginal agent used in patients with stable angina pectoris, which improves cardiac contractility and mitochondrial function.
Bertil Thyrsted Ladefoged   +5 more
wiley   +1 more source

Macrotroponin interference and association with cardiotoxicity in patients receiving cardiotoxic breast cancer therapy: a pilot study. [PDF]

open access: yesCardiooncology
Soosaipillai A   +6 more
europepmc   +1 more source

The ADESTE trial: A phase 2 study of enibarcimab, a monoclonal antibody targeting adrenomedullin, in acute heart failure

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 1848-1860, June 2025.
Abstract Aims This study aimed to conduct a phase 2 proof‐of‐concept and safety study to evaluate the effect of ENIBARCIMAB (EN), a non‐neutralizing humanized monoclonal antibody targeting the N‐terminus of adrenomedullin (ADM), administered immediately after stabilization with standard of care (SoC) treatment, in patients hospitalized for acute heart ...
Anggoro Budi Hartopo   +19 more
wiley   +1 more source

Copeptin in Acute Myocardial Infarction: Is There a Role in the Era of High-Sensitivity Troponins? [PDF]

open access: yesJ Cardiovasc Dev Dis
Bezati S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy